- Home
- Publications
- Publication Search
- Publication Details
Title
NKT Cell Networks in the Regulation of Tumor Immunity
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-10-29
DOI
10.3389/fimmu.2014.00543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
- (2014) Masaki Terabe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimization of Natural Killer T Cell–Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
- (2014) C. Faveeuw et al. CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- IL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
- (2014) Duygu Sag et al. JOURNAL OF CLINICAL INVESTIGATION
- Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells
- (2014) V. Y. Taraban et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy
- (2014) W.-S. Chang et al. JOURNAL OF IMMUNOLOGY
- PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination
- (2014) A. C. Finnefrock et al. JOURNAL OF IMMUNOLOGY
- -Galactosylceramide but Not Phenyl-Glycolipids Induced NKT Cell Anergy and IL-33-Mediated Myeloid-Derived Suppressor Cell Accumulation via Upregulation of egr2/3
- (2014) J.-R. Huang et al. JOURNAL OF IMMUNOLOGY
- Tuberous Sclerosis 1 Promotes Invariant NKT Cell Anergy and Inhibits Invariant NKT Cell-Mediated Antitumor Immunity
- (2014) J. Wu et al. JOURNAL OF IMMUNOLOGY
- Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
- (2014) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity
- (2013) L. Izhak et al. CANCER RESEARCH
- -Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
- (2013) J. J. O'Konek et al. CLINICAL CANCER RESEARCH
- Natural Killer T cell obsession with self-antigens
- (2013) Laurent Gapin et al. CURRENT OPINION IN IMMUNOLOGY
- Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells
- (2013) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells
- (2013) You Jeong Lee et al. NATURE IMMUNOLOGY
- TGF- Signaling in Myeloid Cells Is Required for Tumor Metastasis
- (2013) Y. Pang et al. Cancer Discovery
- NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
- (2013) Shin-ichiro Fujii et al. Frontiers in Immunology
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Invariant NKT cells increase drug-induced osteosarcoma cell death
- (2012) S Fallarini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ex-vivoanalysis of human Natural Killer T cells demonstrates heterogeneity between tissues and within established CD4+and CD4−subsets
- (2012) A. C. Chan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte
- (2012) Sara Rhost et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR
- (2012) Li Bai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intestinal Microbes Affect Phenotypes and Functions of Invariant Natural Killer T Cells in Mice
- (2012) Gerhard Wingender et al. GASTROENTEROLOGY
- Sulfatide inhibits -galactosylceramide presentation by dendritic cells
- (2012) M. Kanamori et al. INTERNATIONAL IMMUNOLOGY
- Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia
- (2012) Alicia E. Najera Chuc et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of T Cells in -Galactosylceramide-Mediated Immunity
- (2012) C. Paget et al. JOURNAL OF IMMUNOLOGY
- CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes
- (2012) N. Kadri et al. JOURNAL OF IMMUNOLOGY
- Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity
- (2012) Sebastian Zeissig et al. NATURE MEDICINE
- iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
- (2012) Ryan L. Bjordahl et al. PLoS One
- Regulation of memory CD4 T-cell pool size and function by natural killer T cells in vivo
- (2012) C. Iwamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development and Function of Invariant Natural Killer T Cells Producing TH2- and TH17-Cytokines
- (2012) Hiroshi Watarai et al. PLOS BIOLOGY
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
- (2011) Sandrine Aspeslagh et al. EMBO JOURNAL
- Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity
- (2011) Jessica J. O’Konek et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin Combined with TGF- Converts Human Invariant NKT Cells into Suppressive Foxp3+ Regulatory Cells
- (2011) L. Moreira-Teixeira et al. JOURNAL OF IMMUNOLOGY
- Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses
- (2011) Pheh-Ping Chang et al. NATURE IMMUNOLOGY
- CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
- (2011) Laura M. Hix et al. PLoS One
- Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy
- (2011) T.-N. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry
- (2010) Jeong-Ju Park et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of α-galactosylceramide
- (2010) Hetty J. Bontkes et al. CLINICAL IMMUNOLOGY
- IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function
- (2010) Moshe Elkabets et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation
- (2010) T. Iyoda et al. INTERNATIONAL IMMUNOLOGY
- Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs
- (2010) Verena Semmling et al. NATURE IMMUNOLOGY
- Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
- (2010) Carmela De Santo et al. NATURE IMMUNOLOGY
- Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a -linked self-glycolipid
- (2010) P. Arrenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Systemic Inhibition of Transforming Growth Factor- in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
- (2009) R. Ueda et al. CLINICAL CANCER RESEARCH
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- TGF-β3 and cancer: A review
- (2009) H.G. Laverty et al. CYTOKINE & GROWTH FACTOR REVIEWS
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1
- (2009) S. Kojo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
- (2009) Prakash Thapa et al. VACCINE
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
- (2008) D. H. Chang et al. BLOOD
- Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
- (2008) G. J. Renukaradhya et al. BLOOD
- Systemic Blockade of Transforming Growth Factor- Signaling Augments the Efficacy of Immunogene Therapy
- (2008) S. Kim et al. CANCER RESEARCH
- Restoration of Tumor Immunosurveillance via Targeting of Interleukin-13 Receptor- 2
- (2008) S. Fichtner-Feigl et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells
- (2008) P. Serafini et al. CANCER RESEARCH
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical role of ROR- t in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
- (2008) M.-L. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now